Advair HFA 230-21 MCG inhaler 12GM
Ended Awarded
- Contract number
- SPE2DR26FHP8F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,457
Award facts
- Contract value 100% obligated
- $10,456.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,456.52 to AmerisourceBergen Drug Corp for the supply of Advair HFA 230-21 mcg inhalers (12 grams) on October 24, 2025, with a completion date of October 27, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. The contract represents a child purchase order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement designated SPE2DX and extending through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical supply vendor that serves military and veteran healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates extensive capability in delivering a comprehensive range of pharmaceutical products, medical supplies, brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The Advair HFA inhaler delivery supports the DLA's broader mission to supply pharmaceutical and medical products necessary for military medical readiness and operations worldwide.
Quick answers
Who was awarded contract SPE2DR26FHP8F?
SPE2DR26FHP8F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DR26FHP8F worth?
The government has obligated $10,457 on SPE2DR26FHP8F.
Is contract SPE2DR26FHP8F an order under another contract?
Yes. SPE2DR26FHP8F is a delivery order under SPE2DR25D1041, an indefinite delivery contract.
Was contract SPE2DR26FHP8F competed?
The extent of competition for SPE2DR26FHP8F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award